• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns

HPV Vaccine enhanced with an adjuvant

June 6, 2011 By Jonathan 1 Comment

VIHC Vaccine Injury Help Center Posted on June 6, 2011 by Vaccine Injury Lawyer According to an article for Medical News Today, “The immune response against the virus that causes cervical cancer is stronger and sustained following vaccination with GlaxoSmithKline’s (GSK) candidate HPV vaccine formulated with the innovative AS04 adjuvant compared to using the same […]

[Continue reading...]

Filed Under: Aluminum Adjuvants, GlaxoSmithKline, HPV, Vaccine Adjuvants, Vaccine Marketing, Vaccine Politics/People Tagged With: aluminium salt adjuvant, GlaxoSmithKline, HPV vaccine, vaccine adjuvants

How safe is Gardasil? ( extracted from the Immunise Australia literature)

June 6, 2011 By Jonathan Leave a Comment

Vaccine Information S.A It is a frustrating time when our young girls and women are being lined up and jabbed with a vaccine that has the potential to affect their future fertility – HPV (Gardasil) vaccine – and that may be the least of the problems. Anyone with a HPV infection (and they are common), […]

[Continue reading...]

Filed Under: Gardasil / Silgard, Immune System, Vaccine Adjuvants, Vaccine Politics/People, Vaccine Science Tagged With: Autoimmune Diseases, Cervical Cancer HPV, Gardasil, HPV, vaccine adjuvants, Vaccine Adverse Reactions

HPV Vaccine Safety and Efficacy: Answers Needed from Government Health Ministers

June 6, 2011 By Jonathan Leave a Comment

  By Judy Wilyman  MSc The One Click Group June 4, 2011 In Australia, as in some other countries, the HPV vaccine – Gardasil® – is being promoted to adolescents, woman and now boys, as a vaccine to prevent cervical cancer. Government health departments are not addressing the concerns of parents. There are many scientific and […]

[Continue reading...]

Filed Under: Australia, Cervical Cancer, Gardasil / Silgard, Vaccine Adjuvants, Vaccine Marketing, Vaccine Science Tagged With: Cervical Cancer HPV, Gardasil, HPV vaccine, vaccine adjuvants, Vaccine Adverse Reactions

UK Government Documents on Aluminium in Vaccines

June 4, 2011 By Jonathan Leave a Comment

Age of Autism The shocking truth about aluminium (aluminum) in vaccines from UK government documents John Heptonstall In September 2010 the Medicines and Healthcare products Regulatory Agency, MHRA, which is the government agency responsible for regulating medicines and medical devices in the UK, reported that there was a risk of aluminium exposure caused by calcium […]

[Continue reading...]

Filed Under: Heavy Metal Toxicity, Vaccine Adjuvants, Vaccine Adverse Events, Vaccine Science Tagged With: aluminum adjuvants, Autoimmune Diseases, HPV, Vaccine Adverse Reactions, vaccine contaminants

Aluminum Toxicity: A misdiagnosed epidemic (Part 1)

May 8, 2011 By Jonathan Leave a Comment

ProLiberty.com From the December 2007 Idaho Observer: By Ingri Cassel Aluminum is the third most abundant element (8 percent) in the Earth’s crust, exceeded by oxygen (47 percent) and silicon (28 percent). Because of its strong affinity to oxygen, aluminum never occurs as a metal in nature but is found only in the form of […]

[Continue reading...]

Filed Under: Aluminum Adjuvants, Heavy Metal Toxicity, Vaccine Adverse Events, Vaccine Preservatives Tagged With: aluminum adjuvants, aluminum poisoning, immunizations, vaccinations, Vaccine Adverse Reactions

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

May 1, 2011 By admin

Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Source Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Abstract Aluminium adjuvants, typically referred to as ‘alum’, are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by […]

[Continue reading...]

Filed Under: Aluminum Adjuvants Tagged With: aluminum adjuvants, humoral adaptive immune response

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

April 4, 2011 By admin

Christopher Exley, Louise Swarbrick, Rhomain K. Gherardi, and Francois-Jérôme Arthier Summary:  Macrophagic myofasciitis and chronic fatigue syndrome are severely disabling conditions which may be caused by  adverse reactions to aluminium-containing adjuvants in vaccines. While a little is known of disease aetiology both conditions are characterised by an aberrant immune response, have a number of prominent […]

[Continue reading...]

Filed Under: Aluminum Adjuvants Tagged With: aluminum adjuvants, chronic fatigue syndrome, macrophagic myofaciitis

The immunobiology of aluminium adjuvants: how do they really work?

April 4, 2011 By admin

Christopher Exley, Peter Siesjö, and Håkan Eriksson  ABSTRACT:  Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant critical mportance in mass vaccination programmes may have prompted recent intense interest in understanding how they work and their safety. Progress in these areas is stymied, however, by […]

[Continue reading...]

Filed Under: Aluminum Adjuvants Tagged With: aluminum adjuvants, immunobiology

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

March 21, 2011 By admin Leave a Comment

McKeage K, Romanowski B; Drugs 71 (4), 465-8 (Mar 2011) The AS04-adjuvanted human papillomavirus (HPV) 16/18 vaccine (Cervarix®) is a noninfectious recombinant vaccine produced using purified virus-like particles (VLPs) that induce a strong immunogenic response eliciting high levels of anti-L1 VLP antibodies that persist at levels markedly greater than those observed with natural infection. The […]

[Continue reading...]

Filed Under: Aluminum Adjuvants, Cervarix Efficacy, Cervarix Product Info. Tagged With: AS04 adjuvant, cervarix, HPV vaccine

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.

January 24, 2011 By admin

J Inorg Biochem. 2009 Nov;103(11):1571-8. Epub 2009 Aug 20. Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ. Abstract Macrophagic myofasciitis (MMF) is an emerging condition, characterized by specific muscle lesions assessing long-term persistence of aluminum hydroxide within macrophages at the site of previous immunization. Affected […]

[Continue reading...]

Filed Under: Aluminum Adjuvants Tagged With: adjuvants, aluminum hydroxide, chronic fatigue syndrome, macrophagic myofaciitis, MMF

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle

January 16, 2011 By admin

Macrophagic myofasciitis (MMF) is an emerging condition of unknown cause, detected in patients with diffuse arthromyalgias and fatigue, and characterized by muscle infiltration by granular periodic acid-Schiff’s reagent-positive macrophages and lymphocytes. Itrracytoplasmic inclusions have been observed in macrophages of some patients….. We conclude that the MMF lesion is secondary to intramuscular injection of aluminum hydroxide-containing […]

[Continue reading...]

Filed Under: Vaccine Adjuvants, Vaccine Ingredient Research Tagged With: adjuvants, arthromyalgia, macrophagic myofaciitis, motor neuron disease

Aluminum adjuvant linked to Gulf War Illness induces motor neuron death in mice

January 16, 2011 By admin

Michael S. Petrik, Margaret C. Wong, Rena C. Tabata, Robert F. Garry and Christopher A. Shaw Abstract Gulf War illness (GWI) affects a significant percentage of veterans of the 1991 conflict, but its origin remains unknown. Associated with some cases of GWI are increased incidences of amyotrophic lateral sclerosis and other neurological disorders. Whereas many […]

[Continue reading...]

Filed Under: Vaccine Adjuvants, Vaccine Ingredient Research Tagged With: adjuvants, adverse events, Gulf War Syndrome, immunization, ingredients, motor deficits, motor neuron degeneration, motor neuron disease, safety, vaccine

New-Age Vaccine Adjuvants: Friend or Foe?

January 16, 2011 By admin

By:  Nikolai Petrovsky, Susanne Heinzel, Yoshikazu Honda, and A. Bruce Lyons A major unsolved challenge in development is how to achieve a potent adjuvant effect while avoiding reactogenicity or toxicity. Older vaccines made from live or killed whole organisms were effective, but suffered from high reactogenicity. As vaccine manufacturers developed safer, less reactogenic subunit vaccines, […]

[Continue reading...]

Filed Under: Vaccine Adjuvants, Vaccine Ingredient Research Tagged With: adjuvants, adverse events, immune response, immunization, local reactions, systemic adverse reactions

Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration

January 16, 2011 By admin

Authors:  Christopher Shaw/Michael Petrik 10 Feb 2010 Abstract:  Gulf War Syndrome is a multi-system disorder afflicting many veterans of Western armies in the 1990–1991 Gulf War. A number of those afflicted may show neurological deficits including various cognitive dysfunctions and motor neuron disease, the latter expression virtually indistinguishable from classical amyotrophic lateral sclerosis (ALS) except […]

[Continue reading...]

Filed Under: Immunization Practices, Vaccine Adjuvants, Vaccine Ingredient Research Tagged With: adjuvants, adverse events, ALS, aluminum hydroxide, amylotropic lateral sclerosis, Gulf War Syndrome, motor deficits, motor neuron degeneration, motor neuron disease, vaccine adjuvants, vaccine information

Synoptic Overview: Issues in Immunization Theory and Practice

January 16, 2011 By admin

Prepared by:  Raymond Obamsowin November 2009 IMMUNIZATION THEORY ISSUES: Theory: Vaccination is the injection of antigenic material, such as pathogen derived foreigh proteins and toxic adjuvants into the body, to initiate a “learned” immune system response in order to prevent particular diseases. Memory T cells (cell-mediated immunity) and Memory B cells (humoral-mediated immunity) learn to […]

[Continue reading...]

Filed Under: Immunization Practices, Vaccine Adjuvants, Vaccine Ingredient Research Tagged With: adjuvants, immune system response, immunization, practices, vaccination

  • « Previous Page
  • 1
  • 2

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed
Vaccine Victims Hotline »

This Week’s Survivor

Cervical Cancer – HPV (human papillomavirus) Vaccination: How Safe Is It?

Cervical Cancer – HPV (human papillomavirus) Vaccination: How Safe Is It?

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers who receive no pay, only expense. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

DESCRIPTION 01/14/2018  TOTAL
Disabled 2,509
Deaths 412
Did Not Recover 11,108
Abnormal Pap Smear 639
Cervical Dysplasia 300
Cervical Cancer 145
Life Threatening 895
Emergency Room 15,145
Hospitalized 5,456
Extended Hosp. Stay 409
Serious 7,894
Total Adverse Events 56,168

Subscribe2


 

Log In

Featured Video

5021 Emergency Room Visits Because of Gardasil, Now Given to Boys

5021 Emergency Room Visits Because of Gardasil, Now Given to Boys

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2018 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in